ApoB-LDL-C Discordance in Young Adults Predicts Coronary Artery Calcification at Midlife: CARDIA

The CARDIA (Coronary Artery Risk Development in Young Adults) study measured ApoB and LDL-C in 2,794 young adults (mean age 25 years at baseline) and assessed coronary artery calcium (CAC) scores at age ~45 — two decades later — examining whether ApoB-LDL-C discordance in young adulthood predicted midlife subclinical coronary atherosclerosis.

Participants with high ApoB but low LDL-C in young adulthood (discordant-high-ApoB group) had significantly greater odds of detectable CAC at midlife (OR 1.55) compared with the concordant-low reference group. The concordant-high (both high ApoB and high LDL-C) group had the highest CAC risk (OR 2.28). ApoB’s predictive association with midlife CAC was stronger than LDL-C or non-HDL-C across all discordance categories.

The CARDIA longitudinal design — measuring lipids in young adults and ascertaining subclinical coronary atherosclerosis 20 years later — provides an unusually long-horizon view of how early lipid exposures translate to coronary plaque accumulation. The finding that elevated ApoB with normal LDL-C in young adults predicts excess coronary calcium in middle age establishes that the ApoB-LDL-C discordance phenomenon has real long-term atherosclerotic consequences, not just theoretical implications.

This is among the most clinically compelling evidence for ApoB measurement in younger patients: the window for prevention is longest, and early discordance detection would identify who needs more aggressive treatment before significant plaque accumulation occurs.

We rate the evidence strong. A 20-year prospective CARDIA cohort study demonstrating that ApoB-LDL-C discordance in young adults — specifically elevated ApoB with normal LDL-C — predicts excess coronary artery calcium at midlife, with ApoB outperforming LDL-C as a predictor across all discordance categories.